1,745
Views
12
CrossRef citations to date
0
Altmetric
Review

How Advancing are Mesoporous Silica Nanoparticles? A Comprehensive Review of the Literature

, , , & ORCID Icon
Pages 1803-1827 | Published online: 22 Apr 2022

Figures & data

Table 1 Chemical Composition of Some Bio-Sources Ash

Figure 1 Effects of pH value on the silica condensation rate, charge properties and charge density on the surface of the silica species.

Notes: Adapted from Wu S-H, Mou C-Y, Lin H-P. Synthesis of mesoporous silica nanoparticles. Chem Soc Rev. 2013;42(9):3862–3875.Citation40
Figure 1 Effects of pH value on the silica condensation rate, charge properties and charge density on the surface of the silica species.

Table 2 Composition of RHA Derived from Calcination of Rice Husk at 600 °C for 12 h

Table 3 Several Biogenic Silica Nanoparticles and Their Applications

Table 4 Chemical Composition Analyzed by XRF, Loss on Ignition, and Total Carbon of Three RHA Types (Wt%)

Figure 2 (A) The overall procedure of mesoporous silica nanoparticles synthesis from rice husk and (B) nanoparticles surface modification synthesis by DBD plasma modification with i) Direct and ii) direct hybrid modes to pH and Temperature-responsive drug delivery system synthesis.

Note: Adapted from J Taiwan Inst Chem Eng, 123, Porrang S, Rahemi N, Davaran S, Mahdavi M, Hassanzadeh B, Gholipour AM. Direct surface modification of mesoporous silica nanoparticles by DBD plasma as a green approach to prepare dual-responsive drug delivery system. 47–58, copyright 2021, with permission from Elsevier.Citation27
Figure 2 (A) The overall procedure of mesoporous silica nanoparticles synthesis from rice husk and (B) nanoparticles surface modification synthesis by DBD plasma modification with i) Direct and ii) direct hybrid modes to pH and Temperature-responsive drug delivery system synthesis.

Figure 3 Stimuli-responsive drug delivery systems based on MSNs. Created with BioRender.com.

Figure 3 Stimuli-responsive drug delivery systems based on MSNs. Created with BioRender.com.

Figure 4 Active targeting strategies based on MSNs. Created with BioRender.com.

Figure 4 Active targeting strategies based on MSNs. Created with BioRender.com.

Figure 5 CLSM images of MSNs-TAT with diameters of (A) 25, (B) 50, (C) 67, and (D) 105 nm after incubation with Hela cells for (i) 4, (ii) 8, and (iii) 24 h. Scale bars: 5 μm.

Figure 5 CLSM images of MSNs-TAT with diameters of (A) 25, (B) 50, (C) 67, and (D) 105 nm after incubation with Hela cells for (i) 4, (ii) 8, and (iii) 24 h. Scale bars: 5 μm.

Figure 6 (A) Schematic illustration of MSN-BM/CD-HApt@DOX synthesis process and (B) the mechanism of targeting and cancer cells apoptosis.

Note: Reproduced from Shen Y, Li M, Liu T, et al.A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells. Int J Nanomedicine. 2019;14:4029-4044. Originally published by and used with permission from Dove Medical Press Ltd.Citation140
Figure 6 (A) Schematic illustration of MSN-BM/CD-HApt@DOX synthesis process and (B) the mechanism of targeting and cancer cells apoptosis.

Figure 7 Schematic illustration of magnetic MSNs drug delivery systems preparation based on targeted and photothermal cancer therapy strategies.

Note: Reproduced from Tran VA, Van Giau Vo KS, Lee S-W, An SSA, An SSA. Multimodal mesoporous silica nanocarriers for dual stimuli-responsive drug release and excellent photothermal ablation of cancer cells. Int J Nanomedicine. 2020;15:7667-7685. Originally published by and used with permission from Dove Medical Press Ltd.Citation144
Abbreviations: APTMS-FITC, 3-AminoPropylTriMethoxySilane-Fluorescein IsoThioCyanate; F, Fe3O4 NPs; S, Silica nanoparticles (MSNs); P, Polydopamine (PDA); G, Graphene oxide; A, Au NPs; E, EGFR antibody; C, Cisplatin; GO, Graphene oxide.
Figure 7 Schematic illustration of magnetic MSNs drug delivery systems preparation based on targeted and photothermal cancer therapy strategies.

Table 5 Some Examples of Drug Delivery Systems Based on MSNs